Brawn Biotech appoints GDSM and Co. as statutory auditors till FY31
- Appointed M/s. GDSM and Co. as statutory auditors effective September 29, 2026
- Auditor tenure extends through FY31 (Financial Year 2030-31)
- Reappointed Brij Raj Gupta as Director following retirement by rotation
- Gupta holds 500,774 equity shares as on March 31, 2026

*this image is generated using AI for illustrative purposes only.
Brawn Biotech Ltd has appointed M/s. GDSM and Co. Chartered Accountants as its statutory auditors with effect from September 29, 2026. The appointment follows shareholder approval at the Annual General Meeting and covers a tenure extending through FY31.
The company disclosed the development to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolution was part of a set of approvals outlined in the notice dated August 13, 2026.
Auditor details and tenure
M/s. GDSM and Co., bearing Firm Registration No. 034194N, will serve as the statutory auditor until the conclusion of the financial year 2030-31. The firm offers a comprehensive range of services including audits under the Companies Act, income tax, GST audit, internal audit, and consultancy in taxation and company law matters.
The disclosure confirms that the appointment is not related to any resignation or removal of the previous auditor but is a fresh appointment approved by members.
Director reappointment
Alongside the auditor appointment, shareholders approved the reappointment of Brij Raj Gupta as Director. Gupta, who retired by rotation at the AGM, continues in his role liable to retire by rotation.
| Detail | Particulars |
|---|---|
| Name | Brij Raj Gupta |
| DIN | 00974969 |
| Age | 74 years |
| Date of Birth | April 15, 1952 |
| Initial Appointment Date | November 7, 1985 |
| Equity Shares Held (as on March 31, 2026) | 500,774 |
| Skills & Experience | Expertise in pharmaceutical business; associated with the company for a long period |
The filing notes that Gupta holds 500,774 equity shares in the company as on March 31, 2026. His initial appointment dates back to November 7, 1985, indicating a long-standing association with the pharmaceutical entity.
Historical Stock Returns for Brawn Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.37% | +14.42% | +2.71% | 0.0% | +16.81% | +23.31% |
How might the new five-year audit tenure with GDSM and Co. influence Brawn Biotech's long-term financial reporting consistency and investor confidence?
Given Brij Raj Gupta's age of 74 and tenure since 1985, what succession planning strategies is the board implementing to ensure leadership continuity?
Will the appointment of GDSM and Co., known for comprehensive tax and compliance services, lead to changes in Brawn Biotech's operational cost structure or tax efficiency?


































